WallStreetZenWallStreetZen

NASDAQ: COYA
Coya Therapeutics Inc Earnings & Revenue

COYA earnings and revenue history

Current Revenue
$6.1M
Current Earnings
-$10.3M
Current Profit Margin
-168.1%

COYA Return on Equity

Current Company
-45.1%
Current Industry
16.8%
Current Market
30.8%
COYA's Return on Equity (-45.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when COYA announces earnings.

COYA Return on Assets

Current Company
-39.2%
Current Industry
3.2%
COYA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

COYA Return on Capital Employed

Current Company
-28.96%
Current Industry
-42.4%

COYA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
COYA$6.13M-$9.55M-$10.30MN/AN/A
CTMX$119.18M$26.34M$16.53M+9.76%N/A
KPTI$140.46M-$121.72M-$146.34M+46.96%N/A
RGLS$0.00-$30.61M-$31.37M-100.00%N/A
CRDF$610.00k-$39.82M-$40.25M+12.39%N/A

Coya Therapeutics Earnings & Revenue FAQ

What were COYA's earnings last quarter?

On Invalid Date, Coya Therapeutics (NASDAQ: COYA) reported Q1 2024 earnings per share (EPS) of -$0.35, up 25% year over year. Total Coya Therapeutics earnings for the quarter were -$5.05 million. In the same quarter last year, Coya Therapeutics's earnings per share (EPS) was -$0.28.

If you're new to stock investing, here's how to buy Coya Therapeutics stock.

What was COYA's earnings growth in the past year?

As of Q3 2024, Coya Therapeutics's earnings has grown year over year. Coya Therapeutics's earnings in the past year totalled -$10.30 million.

What was COYA's revenue last quarter?

On Invalid Date, Coya Therapeutics (NASDAQ: COYA) reported Q1 2024 revenue of $126.84 thousand up Infinity% year over year. In the same quarter last year, Coya Therapeutics's revenue was $0.00.

What was COYA's revenue growth in the past year?

As of Q3 2024, Coya Therapeutics's revenue has grown null year over year. Coya Therapeutics's revenue in the past year totalled $6.13 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.